Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Matthew Bell

1PUBLICATIONS
9CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Nov 30, 2023
Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling.

Matthew Bell, Shannon Lange, Besian I Sejdiu

Pageof 1

Frequent Collaborators

1 joint publications

Jorge Ibanez

1 joint publications

Jessica Wagner

1 joint publications

Deanna Langfitt

1 joint publications

Alejandro Allo Anido

1 joint publications

Mitchell Ho

1 joint publications

Jiyang Yu

1 joint publications

M Madan Babu

1 joint publications

Giedre Krenciute

1 joint publications

Stephen Gottschalk

Frequent Collaborators

1 joint publications

Jorge Ibanez

1 joint publications

Jessica Wagner

1 joint publications

Deanna Langfitt

1 joint publications

Alejandro Allo Anido

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

539
See more related videos

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

539
See more related videos